Genomic Medicine Program at The Ohio State University Department of Ophthalmology and Visual Sciences
The Genomic Medicine Initiative
The Department of Ophthalmology and Visual Sciences is participating in a college-wide collaboration with the department of genomic medicine. This collaboration will help detect patients with inherited eye diseases, conditions and discover advancements in genomic medicine beyond eye care. The Medical Genetics and Genomics Program provides risk assessment, genetic counseling, and when appropriate, genetic testing for the many different conditions that can run in families. These can range from bleeding and blot-clotting disorders to diseases of the skin, kidney, lung, and eye.
The Ophthalmology Department is actively recruiting patients interested in participating in the Genomic Medicine Initiative with Retinal Distrophies, Corneal Dystrophy, Keratoconus, Steroid-induced glaucoma & ocular hypertension, Familial forms of glaucoma, Nanophthalmos, Steroid-induced glaucoma & ocular hypertens, Familial forms of glaucoma, Nanophthalmos, Open-angle forms of glaucoma including: primary, normal tension, exfoliation.
Kara Williams, MS, LGC - Licensed Genetic Counselor
The Department of Ophthalmology and Visual Sciences has recently added Licensed Genetic Counselor counselor Kara Williams, MS, LGC to expand The Genomic Medicine Program at The Ohio State University Wexner Medical Center.
She provides genetic counseling and education of genetic test results for patients with inherited eye diseases and conditions. Kara also works with statistical genetics expert Raymond Gao, PhD, and clinician-scientist Sayoko Moroi, MD, PhD to build the department's program in genetics of eye disease and ocular conditions by enrolling patients in genetics research.
Sayoko Moroi, MD, PhD - Clinician Scientist
Sayoko Moroi, MD, PhD, a glaucoma specialist and chair of the Department of Ophthalmology and Visual Sciences at the Ohio State Wexner Medical Center. She collaborates with a team of scientists and clinicians to determine which patients are most susceptible to glaucoma-related blindness and how best to treat them. Dr. Moroi is passionate about harnessing the power of genetics to shift from “event-based” clinical care to a precision-medicine approach. This shift holds promise to reduce and even prevent glaucoma-related blindness.
Raymond Gao, PhD - Research Faculty
Raymond Gao, PhD, an associate professor in the Department of Ophthalmology and Visual Sciences, Department of Biomedical Informatics and Division of Human Genetics at The Ohio State University, is studying the genetic architecture of eye pressure and developing genetic risk prediction models. Dr. Moroi expects these discoveries to offer new opportunities for eye pressure assessment. Dr. Gao and Dr. Moroi hypothesize that a combination of genes that have already been linked to eye pressure will also predict individuals who will have pressure spikes versus those who have a more flat pressure profile.